PT-141 (Bremelanotide)
PT-141 (Bremelanotide) is studied within hormonal and sexual-wellness research, where investigators examine melanocortin and reproductive-hormone signaling in the central nervous system. It supports controlled study of libido, arousal, and endocrine rhythm.
Executive Summary
PT-141 (Bremelanotide) is studied within hormonal and sexual-wellness research, where investigators examine melanocortin and reproductive-hormone signaling in the central nervous system. It supports controlled study of libido, arousal, and endocrine rhythm.
Research context: PT-141 (Bremelanotide) is studied primarily within sexual wellness research. All information below is presented for educational and reference purposes only.
Discovery History
- 1Discovery
The peptide is characterized within melanocortin or reproductive-hormone signaling.
- 2Research
Studies map its central effects on arousal and hormone release.
- 3Present
Used as a research reference material for neuroendocrine and desire pathways.
Mechanism of Action
Central signaling
Acts on melanocortin or hypothalamic receptors that govern arousal and hormone release.
Neuroendocrine axis
Studied for influence on the reproductive hormone cascade.
Vasoactive response
Explored for downstream effects on desire and physiological response.
Rhythm modulation
Investigated for pulsatile signaling of the endocrine system.
Areas of Scientific Research
Libido & arousal
Central desire and response pathways.
Hormone signaling
LH/FSH and reproductive rhythm.
Endocrine balance
Hypothalamic-pituitary axis.
Mood & bonding
Neuropeptide effects on affect.
Current Research
- 1
Central melanocortin and hypothalamic signaling of arousal.
- 2
Regulation of the reproductive hormone cascade (LH/FSH).
- 3
Pulsatile signaling and endocrine rhythm.
- 4
Neuropeptide effects on mood and bonding.
Safety Information
For laboratory research use only — not for human or veterinary use.
Research use only
PT-141 (Bremelanotide) is supplied strictly as a laboratory research reference material. It is not a drug, supplement, or food, and is not intended for human or veterinary use, consumption, or therapeutic application.
Handling
Handle with appropriate personal protective equipment in a controlled laboratory environment. Avoid inhalation, ingestion, and contact with skin or eyes.
Not clinically evaluated
Statements describe areas of scientific investigation only. No claims of safety or efficacy in humans are made or implied, and the compound has not been evaluated by regulatory agencies for any use.
Qualified personnel
Intended for use only by qualified researchers and institutions familiar with the proper handling of research reference materials.
Storage
Lyophilized (unopened)
Stable at room temperature for short periods; store at -20°C for long-term stability.
After reconstitution
Refrigerate at 2–8°C and use within 2–4 weeks depending on the compound.
Protect from light & heat
Avoid repeated freeze–thaw cycles and prolonged light exposure.
Handling
For laboratory research use only; handle with appropriate protective equipment.
Scientific References
- [1]
Molinoff PB, et al. PT-141 and sexual function research. Annals NY Academy of Sciences, 2003.
- [2]
Skorupskaite K, et al. Kisspeptin and reproductive hormone regulation. Human Reproduction Update, 2014.
- [3]
Pfaus JG. Neurobiology of sexual desire. Journal of Sexual Medicine, 2009.
References are provided for educational context and represent general areas of published literature on this class of compound.
Related TRU Systems
Curated collections that feature PT-141 (Bremelanotide).
Related Compounds
Explore the science of adjacent compounds.
Kisspeptin-10
99% Purity
Research Use Only
Not For Human Consumption
Kisspeptin-10
Read the scienceNAD+
99% Purity
Research Use Only
Not For Human Consumption
NAD+
Read the scienceMelanotan II
99% Purity
Research Use Only
Not For Human Consumption
Melanotan II
Read the scienceSource PT-141 (Bremelanotide) for your research
Third-party tested reference material, from — per vial.